Professor, Obstetrics and Gynecology, Tufts Medical Center
Obstetrics & Gynecology
Dr. Sabrina D. Craigo, MD
|
|
Give Review
Sabrina Craigo is an expert in the field of Obstetrics & Gynecology. She researched medicine at West Virginia University School of Medicine. She received awards:"Boston Magazine" and "Fellow (FACOG)". Sabrina Craigo is also a published doctor. She has 63 publication published. The most recent publication is: Cost issues surrounding the use of computerized telemedicine for obstetric ultrasonography. Sabrina D. Craigo, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- First-Trimester Cystic Hygroma: Relationship of Nuchal Translucency Thickness and Outcomes.
- Indicated preterm birth for fetal anomalies.
- The patient With asymptomatic shortened cervix at 23 to 28 weeks: is delivery imminent?
- Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study.
- The contribution of birth Defects to preterm birth and low birth weight.
- The effect of low body mass index on the development of Gestational hypertension and preeclampsia.
- Nuchal translucency and the risk of Congenital heart disease.
- The association between time of birth and fetal injury resulting in death.
- Pregnancy loss rates after midtrimester amniocentesis.
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are Associated with obstetric complicat...
- Ultrasound-guided procedures for prenatal diagnosis and therapy.
- A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketan...
- Placenta previa With suspected accreta.
- Clinical dilemma in triplet Pregnancy: when is it appropriate to intervene for a jeopardized fetus?
- Rupture of the renal pelvis Associated with intravenous fluid bolus.
- Assisted reproductive technology and Pregnancy outcome.
- Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
- Risk factors for Postpartum antihypertensive medication requirement in severe preeclampsia.
- Managing a pregnant patient With paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
- Paroxysmal nocturnal hemoglobinuria (PNH) and Pregnancy in the era of eculizumab.
- Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down Syndrome markers.
- Maternal smoking during pregnancy and false positive maternal serum alpha-fetoprotein (MSAFP) screening for open neural tube Defects.
- Individualized norms of optimal fetal Growth: fetal Growth potential.
- Contingent screening for Down Syndrome--results from the FaSTER trial.
- First- and second-trimester screening: detection of aneuploidies other than Down Syndrome.
- Role of second-trimester genetic sonography after Down Syndrome screening.
- Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and Normal metaphase karyotype.
- Circulating cell-free DNA levels increase variably following chorionic villus sampling.
- First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome.
- Quad screen as a predictor of adverse Pregnancy outcome.
- Impact of Maternal age on obstetric outcome.
- Early access to prenatal care: implications for racial disparity in perinatal mortality.
- First-trimester or second-trimester screening, or both, for Down''s Syndrome.
- Obesity, obstetric complications and cesarean delivery rate--a population-based screening study.
- Limited prognostic value of a staging system for twin-to-twin transfusion Syndrome.
- Fetal growth in early Pregnancy and risk of delivering low birth weight infant: prospective cohort study.
- Human sexual size dimorphism in early Pregnancy.
- Comparison of serum markers in first-trimester down Syndrome screening.
- Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
- Fetal diaphragmatic hernia and upper limb anomalies suggest Brachmann-de Lange Syndrome.
- The anesthetic management of triplet cesarean delivery: a retrospective case series of Maternal outcomes.
- Pregnancy outcomes after prenatal diagnosis of aneuploidy.
- Antenatal therapy of Smith-Lemli-Opitz Syndrome.
- Cost issues surrounding the use of computerized telemedicine for obstetric ultrasonography.
- Suggested ultrasound parameters for the assessment of fetal well-being during Chronic hemodialysis.
- Liver masses in Pregnancy.
- Cirrhosis and portal hypertension in Pregnancy.
- Gender differences in twin-twin transfusion Syndrome.
- A comparison of neonatal outcomes of age-matched, Growth-restricted twins and Growth-restricted singletons.
- Fetal ovarian cyst decompression to prevent torsion.
- Validation of fetal telemedicine as a new obstetric imaging technique.
- Validation of first-trimester telemedicine as an obstetric imaging technology: a feasibility study.
- Ultrasound predictors of neonatal outcome in Intrauterine growth restriction.
- Outcome of twin gestations complicated by a single anomalous fetus.
- Cervical incompetence and preterm delivery.
- The role of ultrasound in the diagnosis and management of Intrauterine growth retardation.
- Demonstration of spontaneously dividing male fetal cells in Maternal blood by negative magnetic cell sorting and fish.
- The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura.
- The natural history of meconium peritonitis diagnosed in utero.
- First- and second-trimester Down Syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
- Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
- Down Syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele.
Schools
West Virginia University School Of Medicine
Procedures Preformed
- C-Section
- Contraceptive Management
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Gynecologic Cancer Screening
- View All
Conditions Treated
- Antiphospholipid Syndrome (APS)
- Breech Position
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Maternal-Fetal Medicine
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Boston Magazine
- Fellow (FACOG)
Education
-
Charleston Area Medical Center - WVSOM -
West Virginia University School of Medicine
Hospital
-
Cambridge Health Alliance -
Tufts Medical Center
Drug Facts
| NPI NUMBER | 1689640674 | |
| NPPES Provider LastName | CRAIGO | |
| NPPES Provider FirstName | SABRINA | |
| NPPES Provider ZIPCode | 021111526 | |
| NPPES Provider State | MA | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689640674 |
| Last Name Of The Provider | CRAIGO |
| First Name Of The Provider | SABRINA |
| View All |
Similar Doctors
|
|
Dr. Lekha S. Hota, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beth E. Goldbaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miriam D. Goldfarb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merielle M. Stephens, MD
This Doctor is OpenDoctor Recommended.
|